We are honoured to be the winner of Start-up initiatives award from CPHI Pharma Award. This is great recognition of our works to transform respiratory drug delivery. Thanks to the judges, CPHI and also our great team at Nebu~Flow .

We are thrilled to introduce Andrea Cusack as the CEO of Nebu~Flow ! With over 25 years of experience in commercial strategy, M&A, and fundraising in the Life Sciences sector, Andrea is a fantastic addition to guide us towards our vision and drive business success.

We are pleased to announce that Dr. Mike Khan has joined our Board of Directors. With over 25 years of leadership experience in R&D, Michael Khan brings extensive expertise across preclinical, translational, and clinical development to Nebu~Flow. 

Nebu-Flow secures £4.7 million investment to accelerate next-generation respiratory pharmaceuticals, poised to revolutionize drug delivery for respiratory disorders.

“At Nebu~Flow, we are proud to lead the charge in reshaping the future of inhalation drug delivery to treat respiratory disorders,” remarked chairman Dr John Pritchard.